Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: Correlation with competitive radioimmunoassay titer

Journal of Infectious Diseases

Volumn 184, Issue 9, 2001, Pages 1183-1186

  Brown, D R ^a,b   Bryan, J T ^d   Schroeder, J M ^a   Robinson, T S ^a   Fife, K H ^a   Wheeler, C M ^c   Barr, E ^d   Smith, P R ^d   Chiacchierini, L ^d   DiCello, A ^d   Jansen, K U ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterans Administration Hospital   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOGENICITY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SERUM; VACCINATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WART VIRUS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MICE; NEUTRALIZATION TESTS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RADIOIMMUNOASSAY; TUMOR VIRUS INFECTIONS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRION; YEASTS;

EID: 0035500950     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323645     Document Type: Article

References (15)

1. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Laboratory production in vivo of infectious human papillomavirus type 11
4. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
5. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
6. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
7. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
8. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
9. Human papillomavirus type11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast
10. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
11. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: Correlation with virus-like particle IgG concentration
12. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes
13. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae
14. A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers
15. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine